Home / Hepatitis A, Inactivated, Whole Virus / Czechia
CZ ATC J07BC02 · updated 2 Nov 2026
Hepatitis A, Inactivated, Whole Virus shortage in Czechia
Is there a Hepatitis A, Inactivated, Whole Virus shortage in Czechia?
Yes. As of 2 Nov 2026, 1 Hepatitis A, Inactivated, Whole Virus product is reported short in Czechia, the first since 23 Jul 2026. The company estimate for the return is 20 Nov 2026. Main reason: increased demand.
Also short in Italy, Switzerland, Norway. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | HAVRIX JUNIOR MONODOSE 720EU 720EU INJ SUS ISP 1X0,5ML+SJ | GlaxoSmithKline Biologicals S.A., Rixensart | 23 Jul 2026 | 20 Nov 2026 | Increased demand Zvýšené prodeje |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.